Ryotaro Nakamura, M.D.¹, Wael Saber, MD, MS², Michael J Martens, PhD^3*, Alyssa Ramirez^3*, Bart L. Scott, MD⁴, Betul Oran, MD, MS⁵, Eric Leifer, Ph.D.^6*, Roni Tamari, MD⁷, Asmita Mishra, MD^8*, Richard T. Maziarz, MD⁹, Joseph P. McGuirk, DO¹⁰, Peter Westervelt, MD, PhD¹¹, Sumithra Vasu, MD, MBBS¹², Mrinal M. Patnaik, MD, MBBS¹³, Rammurti Kamble, MD¹⁴, Stephen J. Forman, MD¹, Mikkael A. Sekeres¹⁵, Frederick R. Appelbaum, MD⁴, Adam M. Mendizabal, MS^3*, Brent Logan, PhD^16*, Mary M. Horowitz, MD, MS¹⁶ and Corey Cutler, MD, MPH, FRCPC ¹⁷

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
²CIBMTR, Medical College of Wisconsin, Milwaukee, WI
³The Emmes Company, Rockville, MD
⁴Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
⁶Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
⁷Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Knight Cancer Institute, Oregon Health and Science University, Portland, OR
¹⁰Department of Blood and Bone Marrow Transplant, The University of Kansas Medical Center, Kansas City, KS
¹¹Washington University School of Medicine, Saint Louis, MO
¹²Ohio State University Wexner Medical Center, Columbus, OH
¹³Division of Hematology, Mayo Clinic, Rochester, MN
¹⁴Baylor College of Medicine Methodist Hospital, Houston, TX
¹⁵Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
¹⁶Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹⁷Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA

Mahasweta Gooptu, MD¹, Andrew St. Martin, MS^2*, Rizwan Romee, MD³, Mukta Arora, MD⁴, Monzr M. Al Malki, MD⁵, Joseph H. Antin, MD³, Christopher Bredeson, MD, FRCPC, MSc⁶, Claudio G. Brunstein, MD, PhD⁴, Saurabh Chhabra, MD, MS⁷, Ephraim J. Fuchs, MD, MBA⁸, Nilanjan Ghosh, MD, PhD⁹, Michael R. Grunwald, MD⁹, Yoshihiro Inamoto, MD¹⁰, Christopher G. Kanakry, MD^11*, Natasha Kekre, MD, MPH, FRCPC⁶, Joseph P. McGuirk, DO¹², Ian K. McNiece, PhD^13*, Rohtesh S. Mehta, MD, MPH, MS¹⁴, Marco Last Mielcarek, MD^15*, Filipo Milano, MD, PhD¹⁶, Dipenkumar Modi, MD¹⁷, Ran Reshef, MD¹⁸, Mark A. Schroeder, MD¹⁹, Robert J. Soiffer, MD³, Scott R. Solomon, MD²⁰, Edmund K. Waller, PhD, MD²¹ and Mary Eapen, MBBS, MS²²

¹Harvard Medical School, Boston, MA
²CIBMTR Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
⁴Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁵City of Hope, Duarte, CA
⁶Hematology, The Ottawa Hospital General Campus, Ottawa, ON, Canada
⁷Medical College of Wisconsin, Milwaukee, WI
⁸Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
¹⁰Clinical Research Division, Fred Hutchinson Cancer Research Center, Tokyo, Japan
¹¹The Johns Hopkins Sidney Kimmel Comrehensive Cancer Ctr., Baltimore, MD
¹²The University of Kansas Cancer Center, Westwood, KS
¹³CellMED Consulting, Miami, FL
¹⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁶Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁷Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
¹⁸Columbia University Irving Medical Center, New York, NY
¹⁹Division of Oncology, Washington University, St. Louis, MO
²⁰Blood and Marrow Transplant Program, BMT Group of Georgia, Atlanta, GA
²¹Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
²²CIBMTR department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Robert Zeiser, MD¹, Nicola Polverelli, MD, PhD^2*, Ron Ram, MD^3*, Shahrukh K. Hashmi, MD, MPH⁴, Ronjon Chakraverty, BMBS, PhD^5*, Mary E. D. Flowers, MD⁶, Fitzroy Dawkins, MD^7*, Norbert Hollaender, MD^8*, Maanasa Gowda, PharmD^9*, Tommaso Stefanelli, MD^8*, Stephanie J. Lee, MD, MPH⁶, Takanori Teshima, MD¹⁰ and Franco Locatelli, MD, PhD¹¹

¹Medical Center - University of Freiburg, Freiburg Im Breisgau, Germany
²Unit of Blood Diseases and Stem Cell Transplantation; Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia, ITA
³BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁵UCL Cancer Institute; Institute of Immunity and Transplantation, London, United Kingdom
⁶Fred Hutchinson Cancer Research Center, Seattle, WA
⁷Incyte Corporation, Wilmington, DE
⁸Novartis Pharma AG, Basel, Switzerland
⁹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁰Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
¹¹Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome, Italy

Daniel A. Pollyea, MD¹, Amanda Winters, MD, PhD², Craig T. Jordan, PhD³, Clayton Smith, MD⁴ and Jonathan A. Gutman, MD⁵

¹Division of Hematology, University of Colorado Denver, Aurora, CO
²Department of Pediatrics, University of Colorado, Aurora, CO
³Division of Hematology, Department of Medicine, Univ. of Colorado, Denver, Aurora, CO
⁴University of Colorado Denver, Aurora, CO
⁵Division of Hematology, University of Colorado, Aurora, CO

Joshua A Fein, MD^1,2, Roni Shouval, MD, PhD³, Myriam Labopin, MD^4,5*, Fabio Ciceri, MD^6*, Emanuele Angelucci, MD⁷, Didier Blaise, MD⁸, Johanna Tischer^9*, William Arcese, MD, PhD¹⁰, Yener Koc, MD¹¹, Benedetto Bruno, MD^12*, Jose L. Diez-Martin, MD, PhD¹³, Stella Santarone, MD¹⁴, Simona Sica, MD, PhD^15*, Jurjen Versluis^16*, Mohamad Mohty, MD, PhD^17,18 and Arnon Nagler, MD^19,20

¹Department of Internal Medicine, UConn Health, West Hartford, CT
²Department of Internal Medicine, UConn Health, Farmington, CT
³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France
⁵EBMT ALWP, Paris, France
⁶San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy
⁷Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy
⁸Institut Paoli Calmettes, Marseille, France
⁹Department of Internal Medicine III, University Hospital of Munich-Grosshadern, Ludwig-Maximilians University, Munich, Germany, Munich, Germany
¹⁰Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹¹Medicana International, Istanbul, TUR
¹²SSCVD Trapianto di Cellule Staminali, AOU Città della Salute e della Scienza di Torino, Torino, Italy
¹³Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
¹⁴Department of Oncology Hematology, Pescara Hospital, Pescara, Italy
¹⁵Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy; Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy, Roma, Italy
¹⁶Erasmus University Medical Center Cancer Institute, Rotterdam, Rotterdam, Netherlands
¹⁷Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
¹⁸EBMT, Acute Leukemia Working Party, Paris, France
¹⁹EBMT, Acute Leukemia Working Party office, Paris, France
²⁰Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel

Christopher J. Gibson, MD¹, Haesook T. Kim, PhD², H. Moses Murdock, MD³, Bryan Hambley, MD⁴, Lin Zhao, MD^5*, Lisa Green, PhD^6*, Mark Fleharty^6*, Brendan Blumenstiel^6*, Carrie Cibulskis, BSc^6*, Christopher D Gocke, MD^7*, Sarah Nikiforow, MD, PhD^1*, Amy E. DeZern, MD⁴, Vincent T. Ho, MD^1*, Richard J. Jones, MD⁴, Niall Lennon, PhD^6*, Jerome Ritz, MD¹, Robert J. Soiffer, MD¹, Lukasz P. Gondek, MD, PhD⁸ and R. Coleman Lindsley, MD, PhD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁴Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁵Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
⁶Genomics Platform, Broad Institute, Cambridge, MA
⁷Division of Molecular Pathology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
⁸Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD